Yesterday, researchers from Denmark released a preprint* suggesting that use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with severity or mortality in COVID-19. However, this paper leaves the issue quite unsettled. In Denmark, prescriptions are required for all NSAID use except ibuprofen in doses 200 mg or less in packs with no more than 20 tablets. Over-the-counter use of ibuprofen accounts for 15% of all ibuprofen use. As a result, most NSAID use is tracked nationally with databases on who had NSAID prescriptions filled.
NSAID Use in COVID-19 Remains Questionable
NSAID Use in COVID-19 Remains Questionable
NSAID Use in COVID-19 Remains Questionable
Yesterday, researchers from Denmark released a preprint* suggesting that use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with severity or mortality in COVID-19. However, this paper leaves the issue quite unsettled. In Denmark, prescriptions are required for all NSAID use except ibuprofen in doses 200 mg or less in packs with no more than 20 tablets. Over-the-counter use of ibuprofen accounts for 15% of all ibuprofen use. As a result, most NSAID use is tracked nationally with databases on who had NSAID prescriptions filled.